• OFID 2018:5 (Suppl 1) • Poster Abstracts than toxin EIAs to detect colonization rather than true disease. Limited data indicate patients positive by toxin EIA (toxin+) have worse outcomes than those positive by NAAT (NAAT+) only, suggesting toxin EIA detects true infection more often than NAAT. We used multisite CDI surveillance data from the Centers for Disease Control and Prevention's Emerging Infections Program to compare clinical course and outcomes between toxin+ and NAAT+ only patients.
Clinical Manifestations and Outcomes of Clostridium difficile
Methods. This is a descriptive retrospective study of CDI patients admitted to Detroit Medical Center (DMC) from LTCF from January 2009 to December 2017. Patients identified through chart review as having CDI on admission or within 48 hours of admission and without recent AC hospitalization in the prior 4 weeks were included. CDI and CDI severity were defined based on 2017 clinical consensus guidelines. Definitions: CDI-Either presence of diarrhea or evidence of ileus or megacolon and either presence of C. difficile toxin in stool or evidence of pseudomembranous colitis. Severe CDI-Presence of white blood counts ≥15,000 and serum creatinine >1.5 mg/dL. Complicated CDI-Presence of either toxic megacolon, sepsis, systemic inflammatory response syndrome, colonic perforation, or requiring ICU admission. Demographics, medical conditions, laboratory results, prior 60-day antibiotic use, CDI treatment, and outcomes were collected. Patients' follow-up extended 90 days; however, data were limited to hospital charts from index admission or readmission to the same hospital.
Results. Among the 85 patients who met the inclusion criteria, 45 (53%) were female, the mean age was 76 (SD: 16), and the median Charlson index score was 6 (range: 4-8). The common source of prior 60-day antimicrobial exposure was β-lactam/β-lactamase inhibitors (39%), Flagyl (15%), vancomycin (18%). The majority of patients were treated with flagyl (71%), 41% with vancomycin and 17% with concurrent or sequential flagyl and vancomycin. Majority of CDI patients (56%) experienced severe CDI with 25% experiencing complicated CDI. During the 90-day follow-up period, 32% of patients required readmission (within 30 days of discharge) for recurrent CDI and 15% of patients died in the hospital.
Conclusion Background. Clostridium difficile infection (CDI) is a common healthcare-associated infection, particularly among older adults. We used laboratory-confirmed CDI surveillance data from 8 states participating in the Centers for Disease Control and Prevention's Emerging Infections Program linked to claims data for Centers for Medicare and Medicaid Services (CMS) beneficiaries to measure variation in 1-year outcomes associated with CDI.
Methods. A CDI case was defined as a positive C. difficile stool test in 2014 in a person without a positive test in the prior 8 weeks. Cases aged ≥65 years were linked to their CMS beneficiary ID using unique combinations of date of birth, sex, and zip code. Each case was matched to five control beneficiaries who did not link to any case and were residents of the same catchment area. Inclusion criteria were continuous fee-forservice Medicare for the entire study period (1 year before and after event date), and no hospitalization or skilled nursing facility stay with an ICD-9-CM code for CDI in the year prior to their match date. Multivariable logistic regression models were used to compare mortality and hospitalization for 1 year following the event date between beneficiaries with and without CDI, adjusting for age, sex, race, catchment area, chronic conditions, number of hospitalizations in the prior year, and hospitalization status at the time of and 7 days preceding the event date.
Results. Of 5,097 cases aged ≥65, 3,082 (60%) were linked to a CMS ID, and 1,832 (59%) met inclusion criteria. In crude analysis, 34% of beneficiaries with CDI died within 1 year, compared with 5% of beneficiaries without CDI. Beneficiaries with CDI were also more likely to be hospitalized in the subsequent year (54% vs. 17%). Beneficiaries with CDI had a higher adjusted odds of death (adjusted OR 3.01, 95% CI: 2.46, 3.69) and hospitalization within 1 year (adjusted OR 1.93, 95% CI: 1.65, 2.25) than those without CDI.
Conclusion. Older adults with CDI were three times more likely to die in the year following infection and nearly two times more likely to be hospitalized compared with those without CDI, revealing independent long-term risk of poor outcomes. This excess morbidity and mortality supports the need to develop novel CDI prevention strategies for this population.
Disclosures.All authors: No reported disclosures. Background. Prevention of Clostridium difficile infection (CDI) remains a significant healthcare challenge. Risk prediction tools can potentially identify high-risk patients and allow for early prophylactic interventions. Various tools have been studied but none have been widely adopted. Our objective was to develop a simple risk prediction tool to identify medicine inpatients at high risk for developing primary CDI.
Development of a Simple
Methods. We conducted a retrospective, single-centre case-control study including patients admitted to the internal medicine service at our institution with a positive C. difficile polymerase chain reaction assay in loose stool. Controls were randomly selected from the same population. Risk factors for CDI were identified using univariate and multivariate logistic regression analyses. A model was created using variables that minimized Akaike Information Criterion and yielded higher area under the curve values.
Results. A total of 314 patients were included (157 with CDI and 157 controls). Variables included in the final 5-point, 3-variable risk prediction tool were age, modified Horn's index and antibiotic use within 3 months. The tool demonstrated good discrimination with a C statistic of 0.79 and model optimism of 0.04 based on a bootstrap sample of 2,000 replicates.
Conclusion. Our simple 3-variable risk prediction tool based on age, disease severity and recent antibiotic use facilitates rapid bedside assessment by clinicians to
